Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vesicular carcinoma erysipelatodes.

K P Meadows1, C A Egan

  • 1Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, USA. KMeadows@med.utah.edu

Journal of the American Academy of Dermatology
|May 13, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does delay in referral of proliferative diabetic retinopathy from the diabetic eye screening programme lead to visual loss?

Eye (London, England)·2016
Same author

Structural changes of the choroid in sarcoid- and tuberculosis-related granulomatous uveitis.

Eye (London, England)·2015
Same author

A detailed phenotypic description of autosomal dominant cone dystrophy due to a de novo mutation in the GUCY2D gene.

Eye (London, England)·2014
Same author

Localized plaques on the sacral area of a child.

Clinical and experimental dermatology·2008
Same author

Failure of ES-62 to inhibit T-helper type 1 responses to other filarial nematode antigens.

Parasite immunology·2008
Same author

Attitudes and perceptions regarding skin cancer and sun protection behaviour in an Irish population.

Journal of the European Academy of Dermatology and Venereology : JEADV·2007
Same journal

Sexual function is missing from the adverse-effect map of GLP-1 receptor agonists in dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study.

Journal of the American Academy of Dermatology·2026
Same journal

Safety of Biologic Therapy in Psoriasis Patients With Malignancy.

Journal of the American Academy of Dermatology·2026
Same journal

Letter from the Editor: Glucagon-Like Peptide-1 (GLP-1) agonists in dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Rethinking the Occipital Scalp as a Control in Advanced Androgenetic Alopecia.

Journal of the American Academy of Dermatology·2026
Same journal

Parallel-Polarized Dermoscopy for Acral Parallel Pattern Analysis.

Journal of the American Academy of Dermatology·2026
See all related articles

Carcinoma erysipelatodes, a rare inflammatory metastatic carcinoma, presents as a blistering rash. This case highlights its occurrence in metastatic breast cancer, mimicking erysipelas with vesicles and bullae.

Area of Science:

  • Dermatology
  • Oncology
  • Pathology

Background:

  • Carcinoma erysipelatodes is a rare form of cutaneous metastatic disease.
  • It is characterized by an inflammatory, erysipelas-like presentation on the skin.

Observation:

  • A 64-year-old woman with metastatic breast carcinoma developed a blistering, erythematous eruption.
  • The eruption featured vesicles and bullae, clinically resembling erysipelas.

Findings:

  • The patient was diagnosed with carcinoma erysipelatodes.
  • The presence of vesicles and bullae was a key diagnostic feature in this metastatic breast cancer case.

Implications:

  • This case underscores the importance of recognizing carcinoma erysipelatodes in patients with advanced cancer.

Related Experiment Videos

  • Early diagnosis and appropriate management are crucial for patients presenting with such skin manifestations.
  • Further research into the pathogenesis and treatment of inflammatory metastatic carcinoma is warranted.